American Competitiveness 21st Century Act

Immigration Benefits for Victims of Terrorism

Agency Information Collection Activities; Proposals, Submissions, and Approvals: Patents for Humanity Program and Trademarks for Humanity Program

The United States Patent and Trademark Office USPTO as required by the Paperwork Reduction Act of 1995 invites comments on the extension and revision of an existing information collection: 0651-0066 …

Naturalization Applicants with Disabilities

Procedures for Implementing the Waiving of the Oath for Aliens with Certain Disabilities

Family Sponsor Immigration Act of 2002

CSPA- Children of Asylees and Refugees

Agency Information Collection Activities; Proposals, Submissions, and Approvals: Crash Avoidance Warning System Human-Machine Interface Research

The National Highway Traffic Safety Administration NHTSA invites public comments on our intention to request approval from the Office of Management and Budget OMB for a new information collection. Before …

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food, and Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Animal Food

The Food and Drug Administration FDA is announcing that a proposed collection of information has been submitted to the Office of Management and Budget OMB for review and clearance under …

DAA-0611-2023-0003 Department of Health and Human Services Administration for Strategic Preparedness and Response Medical Countermeasures

Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Genotoxicity Testing (Revision 2); VICH GL23(R2); Guidance for Industry; Draft Guidance; #116

Determination of Regulatory Review Period for Purposes of Patent Extension; Vyndaqel

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for VYNDAQEL and is publishing this notice of that determination as required by law. FDA …

Live Biotherapeutic Products To Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants; Public Workshop; Request for Comments

The Food and Drug Administration FDA or Agency the Centers for Disease Control and Prevention CDC the National Institutes of Health NIH the National Institute of Allergy and Infectious Diseases …

Determination of Regulatory Review Period for Purposes of Patent Extension; EXXUA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for EXXUA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; Vyndamax

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for VYNDAMAX and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Development of an Enhanced Systematic Process for the Food and Drug Administration’s Post-Market Assessment of Chemicals in Food; Public Meeting; Request for Comments

The Food and Drug Administration FDA or we is announcing the following public meeting entitled Development of an Enhanced Systematic Process for FDA's Post-Market Assessment of Chemicals in Food. This …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …